Hi-Tech Pharmacal Co. (HITK) Beats Q4 Views on Top and Bottom
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Price: $43.49 --0%
Financial Fact:
Income from continuing operations before income tax expense: 12.31M
Today's EPS Names:
GLDG, PGR, CMTL, More
Financial Fact:
Income from continuing operations before income tax expense: 12.31M
Today's EPS Names:
GLDG, PGR, CMTL, More
Join SI Premium – FREE
Hi-Tech Pharmacal Co, Inc. (NASDAQ: HITK) reported Q4 EPS of $1.08, $0.37 better than the analyst estimate of $0.71. Revenue for the quarter came in at $57.2 million versus the consensus estimate of $49.33 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- State Street (STT) Tops Q3 EPS by 2c
- UnitedHealth Group (UNH) Tops Q3 EPS by 57c, Beats on Revenue; Offers FY EPS Guidance
- Johnson & Johnson (JNJ) Tops Q3 EPS by 6c; adjusts forecast
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
